| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.84▲ | 9.89▼ | 9.90▼ | 9.82▲ | 9.27▲ |
| MA10 | 9.85▼ | 9.90▼ | 9.98▼ | 9.95▼ | 9.54▲ |
| MA20 | 9.86▼ | 10.06▼ | 10.08▼ | 9.43▲ | 10.60▼ |
| MA50 | 9.90▼ | 9.89▼ | 9.97▼ | 9.47▲ | 13.93▼ |
| MA100 | 10.02▼ | 9.98▼ | 9.75▲ | 10.64▼ | 15.10▼ |
| MA200 | 10.13▼ | 9.71▲ | 9.25▲ | 12.42▼ | 13.67▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | -0.036▼ | -0.051▼ | 0.075▲ | 0.169▲ |
| RSI | 43.308▼ | 41.281▼ | 46.137▼ | 52.404▲ | 43.075▼ |
| STOCH | 24.314 | 33.863 | 13.689▼ | 45.894 | 29.763 |
| WILL %R | -72.727 | -82.927▼ | -93.578▼ | -51.232 | -65.765 |
| CCI | -27.132 | -88.488 | -76.792 | 28.091 | -12.579 |
|
Saturday, October 11, 2025 05:13 AM
NRIX stock is rated Strong Buy as bexobrutideg advances in CLL trials. See here for NRIX stock's milestones, market potential, and key risks.
|
|
Thursday, October 09, 2025 01:45 PM
SAN FRANCISCO - Nurix Therapeutics, Inc. (NASDAQ:NRIX) shares plunged 9.5% after the clinical-stage biopharmaceutical company reported third-quarter financial results that fell short of analyst ...
|
|
Thursday, October 09, 2025 01:16 PM
Announced clinical development plans for bexobrutideg, including the initiation of pivotal trials in relapsed/refractory CLL in H2 2025 Presented preclinical data at EADV 2025 for GS-6791 (NX-0479), a ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/10/25 | 9.83 | 10.1741 | 9.71 | 9.84 | 603,740 |
| 16/10/25 | 10.44 | 10.86 | 10.03 | 10.03 | 968,186 |
| 15/10/25 | 9.18 | 10.43 | 9.18 | 10.35 | 1,327,063 |
| 14/10/25 | 9.43 | 9.70 | 9.14 | 9.18 | 1,270,209 |
| 13/10/25 | 9.84 | 9.905 | 9.00 | 9.72 | 1,566,225 |
| 10/10/25 | 9.71 | 10.56 | 9.50 | 9.76 | 1,996,741 |
| 09/10/25 | 10.03 | 10.88 | 10.03 | 10.86 | 1,147,774 |
| 08/10/25 | 9.96 | 10.33 | 9.85 | 9.98 | 1,011,871 |
| 07/10/25 | 10.09 | 10.139 | 9.69 | 9.83 | 615,578 |
| 06/10/25 | 9.44 | 10.235 | 9.43 | 9.95 | 1,722,001 |
|
|
||||
|
|
||||
|
|